Covered recently in the prestigious journal Nature Medicine, BiomedGPT is a new a new type of artificial intelligence (AI) designed to support a wide range of medical and scientific tasks.
The study was conducted with 50 U.S.-licensed physicians in family medicine, internal medicine and emergency medicine.
The computational tool is called PIONEER (Protein-protein InteractiOn iNtErfacE pRediction). Researchers demonstrated PIONEER's utility by identifying potential drug targets for dozens of cancers and other complex diseases in a recently published Nature Biotechnology article.
In a test whose results were published today, the video system recognized and identified, with high proficiency, which medications were being drawn in busy clinical settings.
The study results, published in the October 21, 2024 online edition of the New England Journal of Medicine (NEJM) AI,